BioHarvest Sciences Inc.
BioHarvest Sciences Inc.
CSE Index:
Currency:
BioHarvest Sciences has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at industrial scale, without the need to grow the plant itself. This technology is economical, ensures consistency, and avoids the negative environmental impacts associated with traditional agriculture. BioHarvest is currently focused on nutraceuticals and the medicinal cannabis markets.
BioHarvest Sciences Inc. (BHSC)
SEDAR Information
Company Info
Address
1140 - 625 Howe St.
Vancouver, BC V6C 2T6
CanadaPhone
604-622-1186Fax
604-685-9182Email
info@bioharvest.comWebsite
http://www.bioharvest.comListing date
Tuesday, August 4, 2015Transfer Agent
National Securities Administrators Ltd.Auditor
BDOCapitalization
Issued & Outstanding:
466,490,450Reserved for Issuance:
62,837,974Company Officers
David Ryan, Vice President of Investor Relations, Secretary & Director
Zaki Rakib, Chairman & Director
Vivien Rakib, Director
Yochi Hagay, CTO
Alan Rootenberg, CFO
Jake Fiddick, Director
Ilan Sobel, CEO
David Tsur, Director
Bulletins
21/04/2020
2020-0428 – Fundamental Change - Canna-V-Cell Sciences Inc./BioHarvest Sciences Inc.
Le 21 avril/April 2020
BioHarvest Sciences Inc., the issuer resulting from a Fundamental Change of Canna-V-Cell Sciences Inc., has been approved for listing.
Listing and disclosure documents are available at www.thecse.com.
Advertisement
Publicité
